Pfizer Inc. (PFE:NYSE)

NEW LONDON -- It took a lot more than the promise of spiffed-up surroundings and the desire of a top executive to help a struggling city to bring Pfizer Inc. to New London. It also took money.

The U.S. Food and Drug Administration has approved top-selling Abilify as a treatment for autism-related irritability in children from the ages of 6 to 17, drug maker Bristol-Myers Squibb Co. said Friday. Bristol-Myers and Otsuka Pharmaceutical Co., based in Tokyo, are collaborators on the development and distribution of Abilify in the U.S. and Europe.

Shares of some top pharmaceuticals companies were mixed at the close of trading: Baxter fell $.62 or 1.1 percent, to $54.33. Bristol-Myers Squibb rose $.43 or 1.8 percent, to $24.46. Hospira fell $.23 or .5 percent, to $46.88. Johnson & Johnson rose $.37 or .6 percent, to $62.31. King Pharmaceuticals rose $.04 or .3 percent, to $11.80. Eli Lilly rose $.47 or 1.3 percent, to $36.59. Merck rose $...

Wyeth, a US-based health-care company specialising in child nutrition, is on course to increase its sales revenue in Thailand by double digits this year despite the expected flat volume growth of baby formula.

Data Show Geodon Used as an Adjunct to Lithium or Valproate Is Effective in the Maintenance Treatment of Bipolar I Disorder. Pfizer today announced that the U.S. Food and Drug Administration has approved Geodon® Capsules for maintenance treatment of bipolar I disorder as an adjunct to lithium or valproate in adults.

Shares of some top pharmaceuticals companies are mixed at noon: Baxter fell $.56 or 1.0 percent, to $54.39. Bristol-Myers Squibb rose $.11 or .5 percent, to $24.14. Hospira fell $.40 or .8 percent, to $46.71. Johnson & Johnson rose $.32 or .5 percent, to $62.26. King Pharmaceuticals rose $.18 or 1.5 percent, to $11.94. Eli Lilly rose $.29 or .8 percent, to $36.41. Merck rose $.86 or 2.4 percent...

Drug developer Pfizer Inc. said Friday the Food and Drug Administration approved an intravenous version of its high blood pressure drug Revatio. The drug was already sold as a tablet. Shares of Pfizer rose 14 cents to $18.25 in morning trading.

Shares of some top pharmaceuticals companies are mixed at 10 a.m.: Baxter fell $.13 or .2 percent, to $54.82. Bristol-Myers Squibb rose $.08 or .3 percent, to $24.11. Hospira fell $.27 or .6 percent, to $46.84. Johnson & Johnson rose $.20 or .3 percent, to $62.14. King Pharmaceuticals rose $.04 or .3 percent, to $11.80. Eli Lilly rose $.04 or .1 percent, to $36.16. Merck rose $.64 or 1.8 percen...

A prominent San Francisco antitrust attorney said Thursday he has filed a request in federal court for a temporary restraining order against Pfizer Inc. to try to roll back its merger with Wyeth Pharmaceuticals and prevent the closure of six research-and-development sites, including one in New London.